Polysaccharide exotoxoid conjugate vaccines

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 88, 536 11, A61K 39108, A61K 3909, A61K 39385, A61K 39102, C07K 1500

Patent

active

046198288

ABSTRACT:
A water-soluble covalent polysaccharide-antigen conjugate having a molecular size between 140,000 and 4,500,000 dalton and a nominal polysaccharide/protein ratio between 0.25 and 2, capable of producing T-cell dependent antibody response to polysaccharide from a number of pathogenic bacterial organisms is prepared by mixing T-cell dependent antigen with an electrophilically activated polysaccharide hapten which polysaccharide had previously been heat sized until more than 60% attained a molecular size between 200,000 and 2,000,000 dalton.

REFERENCES:
patent: 4356170 (1982-10-01), Jennings et al.
Schneerson, R., et al., J. Exp. Med., vol. 152, pp. 361-376, 1980.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Polysaccharide exotoxoid conjugate vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polysaccharide exotoxoid conjugate vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polysaccharide exotoxoid conjugate vaccines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1345574

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.